Brief: Avenue Therapeutics Announces Regulatory Update Based On Type C Meeting With FDA

Avenue Therapeutics

17/04/2023 21:23

April 17 (Reuters) - Avenue Therapeutics Inc  ATXI.O :
    * AVENUE THERAPEUTICS ANNOUNCES REGULATORY UPDATE BASED ON
TYPE C
MEETING WITH FDA AND NEXT STEPS IN THE DEVELOPMENT OF IV
TRAMADOL
    * AVENUE THERAPEUTICS- TYPE C MEETING MINUTES FROM FDA
INDICATE
FDA AND AVENUE THERAPEUTICS ARE IN AGREEMENT WITH A MAJORITY OF
PROPOSED PROTOCOL ITEMS
    * AVENUE THERAPEUTICS-PLAN TO PROVIDE UPDATES ON OTHER TWO
PROGRAMS LATER THIS YEAR INCLUDING AJ201 CLINICAL TRIAL AND
CONTINUED DEVELOPMENT OF BAER-101

Source text for Eikon:  ID:nGNX8zksgc 
Further company coverage:  ATXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))